RecruitingNCT06307327

Comparative Study of New Classification and Traditional Classification of Radioactive Oropharyngeal Mucositis

A Comparative Study on the Evaluation Consistency Between the New Type and the Traditional Grade of Radioactive Oropharyngeal Mucositis and the Exploration of Blood Markers


Sponsor

Nanfang Hospital, Southern Medical University

Enrollment

264 participants

Start Date

Sep 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Radiation oropharyngeal mucositis is one of the most painful side effects of radiotherapy in patients with head and neck tumors. However, the traditional radioactive oropharyngeal mucositis grading system has the problem of poor evaluation consistency. To solve this problem, we innovatively classify radiation oropharyngeal mucositis into four types according to the four-stage histopathological changes of acute radiation injury: (1) congestive; (2) Scattered erosion type; (3) Fusion erosion type; (4) Ulcer type. We intend to conduct a multicenter observational cohort study to compare the consistency of different physicians in the assessment of radiation oropharyngeal mucositis with new and traditional classifications, and to explore changes in blood markers of different types of oropharyngeal mucositis using clinical residual blood samples.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study compares a new grading system for rating the severity of mouth and throat sores (oral mucositis) caused by radiation therapy in head and neck cancer patients against the traditional grading system, to see which one better reflects how patients actually feel. **You may be eligible if...** - You are 18 years or older - You have a confirmed head and neck tumor (diagnosed by biopsy) - You are receiving radiation therapy or combined chemotherapy and radiation therapy - You can provide written informed consent **You may NOT be eligible if...** - You have other serious uncontrolled medical conditions, such as unstable heart disease, poorly controlled diabetes, serious mental illness, or a history of severe allergic reactions Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(4)

Southern medical university

Guangzhou, Guangdong, China

Huizhou Central People's Hospital

Huizhou, Guangdong, China

Jieyang people's hospital

Jieyang, Guangdong, China

Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou

Meizhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06307327


Related Trials